Related Experiment Videos
Malignant lymphoma versus sarcoma: discordance between clinical course and immunocytochemistry. Two case reports
U Kaiser1, K H Pflüger, M Tiemann
1Department of Haematology and Oncology, Philipps-Universität Marburg, Germany.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Sport as a means to prevention, rehabilitation, and health promotion. An expert opinion].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2013
A novel small-cell lung carcinoma-specific DNA-binding activity related to the transcription factor ap-1.
International journal of oncology·2011
[Coincidence of adenocarcinoma and MALT lymphoma of the prostate--first report].
Aktuelle Urologie·2009
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Tumor Budding Unveiled: Clinicopathological Correlations and Survival Insights From a Tertiary Care Cancer Center of India.
International journal of breast cancer·2026
Regulatory T cells in the bladder cancer tumor microenvironment: mechanisms of immune suppression and therapeutic opportunities.
Frontiers in molecular biosciences·2026
Inflammatory myofibroblastic tumor of the larynx: a case report.
Frontiers in oncology·2026